- Home
- EDUC vs CVKD Comparison
EDUC vs CVKD Comparison
Compare EDUC & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EDUC | CVKD |
|---|---|---|
| Founded | 1965 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Specialties | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.7M | 9.9M |
| IPO Year | 1995 | 2022 |
Fundamental Metrics
Financial Performance| Metric | EDUC | CVKD |
|---|---|---|
| Price | $1.29 | $4.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | 12.6K | ★ 41.9K |
| Earning Date | 05-18-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 23.94 |
| EPS | ★ 0.63 | N/A |
| Revenue | ★ $34,191,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.10 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.01 | $4.21 |
| 52 Week High | $1.84 | $17.50 |
Technical Indicators
Market Signals| Indicator | EDUC | CVKD |
|---|---|---|
| Relative Strength Index (RSI) | 54.00 | 37.27 |
| Support Level | $1.25 | $4.21 |
| Resistance Level | $1.36 | $14.21 |
| Average True Range (ATR) | 0.06 | 0.68 |
| MACD | 0.00 | -0.13 |
| Stochastic Oscillator | 76.40 | 19.60 |
Price Performance
Historical ComparisonAbout EDUC Educational Development Corporation
Educational Development Corp is the United States trade publisher of the line of educational children's books produced in the United Kingdom. Its business activity functions with two reportable segments: PaperPie and Publishing. The Publishing Division segment markets its products to retail accounts, which include books, school supplies, toy and gift stores and museums, through commissioned sales representatives, trade and specialty wholesalers and an internal telesales group.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.